By Sabela Ojea
Acadia Pharmaceuticals said its head of research and development, Doug Williamson, is leaving after less than a year since joining the company.
The biopharmaceutical company on Tuesday said it has initiated a search for Williamson’s replacement.
Williamson…
Master your money.
Subscribe to MarketWatch.
Get this article and all of MarketWatch.
Access from any device. Anywhere. Anytime.
Subscribe Now
Already a subscriber?
Log In
Read the full article here
